Skip to content
Building Construction, Medical Health Aged Care

Engineered stone importation ban welcome but real-time dust monitoring needed to protect Australian workers

Trolex 3 mins read

Yesterday’s announcement that Australia will lead the world in banning the importation of engineered stone is another positive move in the fight to protect workers from silicosis, but research shows more needs to be done.

 

Glyn Pierce-Jones, CEO of leading workplace safety technology company, Trolex, said “many Australian workers still face serious health risks, even with the much-welcomed banning  of engineered stone”.

 

“Even with engineered stone out of the picture and strong workplace safety regulations - as strong as any in the world - Australian worksites still carry risks that can only be reduced if real-time dust monitoring is introduced,” Mr Pierce-Jones said.

 

A recent US study should raise alarm bells in Australia about whether more needs to be done following bans to protect workers and others from RCS, even where mandated safety measures have been put in place by employers.   

 

The study, published in the Annals of Work Exposures and Health, examined the levels of background RCS on a construction site in Colorado.

 

Personal worker and area background silica samples were taken over 13 days and involved workers working on dried concrete/mortar.

 

The site followed Occupational Safety and Health Administration (OSHA) guidelines designed to protect workers from RCS exposure above the permissible exposure limit of 50 μg m−3. The same exposure limit applies across Australian workplaces.

 

The OSHA guidelines include dust control measures such as dust suppression with water, HEPA filtration vacuum collection systems and drill shrouds.

 

The results suggest that dust controls were inadequate for a number of construction activities, including a walk-behind saw (126 μg m−3), dowel drilling (99.9 μg m−3), and grinding (172 μg m−3).

 

The study’s authors concluded that “managers and employees may assume that they will not be over-exposed to silica while employing the mandated dust controls”. 

 

The authors continued that the results of their study suggested that even with the implementation of dust controls and work practices, employees may still be at risk of silica exposure above the OSHA Permissible Exposure Limits.

 

“The results indicate that exposure to hazardous levels of RCS can still occur with the OSHA-mandated controls fully implemented and that exposure to RCS may have been exacerbated from background silica concentrations,” the authors concluded.

 

As in Australia, real-time air monitoring is not required of employers complying with OSHA dust controls.

 

However, the results of the US study suggest that real-time air monitoring may still be warranted to identify employees who are at an increased risk of silica exposure.

 

The study should be a wakeup call for Australia.

 

Countries around the world - particularly the UK - are on a fast track to replicate the ban on engineered stone that  Australia is implementing as a guard against the scourge of silicosis.

 

Engineered stone was the cause of an unprecedented spike in cases of silicosis from the inhalation of respirable crystalline silica (RCS).

 

Both bans are well overdue, but there is a very real risk that workers and employers could be lulled into a false sense of security.

 

Work safety agencies in Australia were alerted to the dangers of manufactured stone not because of improved monitoring but by the dramatic increase in cases of silicosis.

 

Studies such as one conducted in 2023 by Monash University School of Public Health and Preventive Medicine, found one quarter of people who had worked with engineered stone benchtops developed silicosis.

 

According to the study co-author, Emeritus Professor Malcolm Sim, “poor dust control measures have been widely reported in the industry”.

 

Why should we conclude that those dust control measures have improved, especially now that engineered stone is banned. 

 

There is now the very real risk of complacency, with engineered stone out of the picture. Yet, natural stone, concrete, tiles and bricks still pose a significant risk.

 

Engineered stone brought the danger of RCS into sharp relief because it was impossible to miss the scourge it caused. The bans are a crucial step in the right direction and now is the time to shine a light on the hidden dangers of background RCS with real-time monitoring.


About us:

About Trolex

 

Trolex is a leader in the manufacturing of state-of-the-art particulate monitoring and fixed multi-gas detection systems. Privately owned and founded in the United Kingdom over 60 years ago, we have been at the forefront of innovative safety products to protect workers in challenging environments. 

 

We collaborate with and support leading corporations and governments across nearly 50 countries, including Australia, USA, Turkey, Canada and Europe, focusing on the eradication of harming working conditions for all.


For more information: https://trolex.com/


Contact details:

Please contact trolex@iconagency.com.au for any media inquiries or more information.

 

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.